Latigo Biotherapeutics Inc. (LTGO) Stock Overview
Explore Latigo Biotherapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.
Latigo Biotherapeutics Inc. (LTGO)
Key Financials
Key Financials
Market Cap
1.1B
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
N/A
LTGO Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Latigo Biotherapeutics Inc. (NASDAQ: LTGO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Latigo Biotherapeutics Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of LTGO on the NASDAQ shows an RSI of 100.00, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.
Key metrics behind Latigo Biotherapeutics Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 1.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LTGO on the NASDAQ.